{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:22Z","timestamp":1761129562716},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Public Health Pol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1057\/s41271-018-0138-8","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T11:36:00Z","timestamp":1531740960000},"page":"268-282","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["What treating Ebola means for pandemic influenza"],"prefix":"10.1057","volume":"39","author":[{"given":"David S.","family":"Fedson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"138_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","volume":"20","author":"A Leligdowicz","year":"2016","unstructured":"Leligdowicz A, Fischer WA II, Uyeki TM, et al. Ebola virus disease and critical illness. Crit Care. 2016;20:217. \n                    https:\/\/doi.org\/10.1186\/s13054-016-1325-2\n                    \n                  .","journal-title":"Crit Care"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMoa1504874","volume":"374","author":"TM Uyeki","year":"2016","unstructured":"Uyeki TM, Mehta AK, Davey RT Jr, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374:636\u201346. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1504874\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/infdis\/jiw496","volume":"215","author":"FG Hayden","year":"2017","unstructured":"Hayden FG, Friede M, Bausch D. Experimental therapies for Ebola virus disease: what have we learned? J Infect Dis. 2017;215:167\u201370. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiw496\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(17)30234-7","volume":"17","author":"A Rojek","year":"2017","unstructured":"Rojek A, Horby P, Dunning J. Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis. 2017;17:e280\u201392. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(17)30234-7\n                    \n                  .","journal-title":"Lancet Infect Dis."},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/science.351.6268.12","volume":"351","author":"J Cohen","year":"2016","unstructured":"Cohen J, Enserink M. As Ebola epidemic draws to a close, a thin scientific harvest. Science. 2016;351:12\u20133. \n                    https:\/\/doi.org\/10.1126\/science.351.6268.12\n                    \n                  .","journal-title":"Science"},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","volume":"95","author":"KJ Rothman","year":"2005","unstructured":"Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95:S144\u201350.","journal-title":"Am J Public Health"},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1038\/srep11030","volume":"5","author":"MG Sugiyama","year":"2015","unstructured":"Sugiyama MG, Armstrong SM, Wang C, et al. The Tie2-agonist Vasculotide rescues mice from influenza virus infection. Sci Rep. 2015;5:11030. \n                    https:\/\/doi.org\/10.1038\/srep11030\n                    \n                  .","journal-title":"Sci Rep."},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"e00716","DOI":"10.1128\/mBio.00716-15","volume":"6","author":"DS Fedson","year":"2015","unstructured":"Fedson DS, Jacobson JR, Rordam OM, Opal SM. Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers. mBio. 2015;6:e00716. \n                    https:\/\/doi.org\/10.1128\/mbio.00716-15\n                    \n                  .","journal-title":"mBio."},{"key":"138_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2015.04.019","volume":"36","author":"DS Fedson","year":"2015","unstructured":"Fedson DS, Rordam OM. Treating Ebola patients: a \u201cbottom up\u201d approach using generic statins and angiotensin receptor blockers. Int J Infect Dis. 2015;36:80\u20134. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2015.04.019\n                    \n                  .","journal-title":"Int J Infect Dis."},{"key":"138_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1253\/circj.CJ-13-1494","volume":"78","author":"HY Lee","year":"2014","unstructured":"Lee HY, Sakuma I, Ihm SH, Goh CW, Koh KK. Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease. Circ J. 2014;78:281\u20137.","journal-title":"Circ J."},{"key":"138_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/atm.2016.11.03","volume":"4","author":"DS Fedson","year":"2016","unstructured":"Fedson DS. Treating the host response to emerging virus diseases: lesson learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med. 2016;4:421.","journal-title":"Ann Transl Med."},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/ciw452","volume":"63","author":"K Rosenke","year":"2016","unstructured":"Rosenke K, Adjemian J, Munster VJ, et al. Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients. Clin Infect Dis. 2016;63:1026\u201333. \n                    https:\/\/doi.org\/10.1093\/cid\/ciw452\n                    \n                  .","journal-title":"Clin Infect Dis."},{"key":"138_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504605","volume":"374","author":"E Gignoux","year":"2016","unstructured":"Gignoux E, Azman AS, de Smet M, et al. Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 2016;374:23\u201332. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1504605\n                    \n                  .","journal-title":"N Engl J Med."},{"key":"138_CR14","doi-asserted-by":"publisher","first-page":"679090","DOI":"10.1155\/2012\/679090","volume":"2012","author":"MC Souza","year":"2012","unstructured":"Souza MC, Paix\u00e3o FH, Ferraris FK, Ribeiro I, Henriques Md. Artesunate exerts a direct effect on endothelial cell activation and NF-\u03baB translocation in a mechanism independent of plasmodium killing. Malar Res Treat. 2012;2012:679090. \n                    https:\/\/doi.org\/10.1155\/2012\/679090\n                    \n                  .","journal-title":"Malar Res Treat."},{"key":"138_CR15","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1038\/ncomms8688","volume":"6","author":"M Hacke","year":"2015","unstructured":"Hacke M, Bjorkholm P, Hellwig A, et al. Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol. Nat Commun. 2015;6:7688. \n                    https:\/\/doi.org\/10.1038\/ncomms8688\n                    \n                  .","journal-title":"Nat Commun."},{"key":"138_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/ijmm.2014.1761","volume":"34","author":"P Mehrbod","year":"2014","unstructured":"Mehrbod P, Hair-Bejo M, Tengku Ibrahim TA, et al. Simvastatin modulates cellular components in influenza A virus-infected cells. Int J Mol Med. 2014;34:61\u201373. \n                    https:\/\/doi.org\/10.3892\/ijmm.2014.1761\n                    \n                  .","journal-title":"Int J Mol Med."},{"key":"138_CR17","doi-asserted-by":"publisher","first-page":"e00660-18","DOI":"10.1128\/mBio.00660-18","volume":"9","author":"P Shrivastava-Ranjan","year":"2018","unstructured":"Shrivastava-Ranjan P, Flint M, Bergeron \u00c9, et al. Statins\u00a0suppress\u00a0Ebola\u00a0virus infectivity by interfering with glycoprotein processing. MBio. 2018;9:e00660-18. \n                    https:\/\/doi.org\/10.1128\/mbio.00660-18\n                    \n                  .","journal-title":"MBio."},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","volume":"13","author":"D Sissoko","year":"2016","unstructured":"Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1001967\n                    \n                  .","journal-title":"PLoS Med."},{"key":"138_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.345.6198.718","volume":"345","author":"M Enserink","year":"2014","unstructured":"Enserink M. Debate erupts on \u2018repurposed\u2019 drugs for Ebola. Science. 2014;345:718\u20139. \n                    https:\/\/doi.org\/10.1126\/science.345.6198.718\n                    \n                  .","journal-title":"Science"},{"key":"138_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/infdis\/jiu474","volume":"211","author":"DS Fedson","year":"2015","unstructured":"Fedson DS. A practical treatment for patients with Ebola virus disease. J Infect Dis. 2015;211:661\u20132. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiu474\n                    \n                  .","journal-title":"J Infect Dis."},{"key":"138_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-134-4-200102200-00017","volume":"134","author":"JP Vandenbroucke","year":"2001","unstructured":"Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001;134:330\u20134.","journal-title":"Ann Intern Med."},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/bmj.39070.527986.68","volume":"334","author":"P Glasziou","year":"2007","unstructured":"Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007;334:349\u201351.","journal-title":"BMJ."},{"key":"138_CR23","doi-asserted-by":"publisher","unstructured":"US National Academies of Sciences, Engineering, and Medicine. Committee on Clinical Trials During the 2014-2015 Ebola Outbreak. 2017. Integrating clinical research into epidemic response: the Ebola experience. Washington DC: The National Academies Press; 2017. \n                    https:\/\/doi.org\/10.17226\/24739\n                    \n                  .","DOI":"10.17226\/24739"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/jeccm.2017.05.03","volume":"1","author":"DS Fedson","year":"2017","unstructured":"Fedson DS. Observational studies help us understand how to treat pandemic influenza and other emerging virus diseases. J Emerg Crit Care Med. 2017;1:10.","journal-title":"J Emerg Crit Care Med."},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1056\/NEJMra1614394","volume":"377","author":"TR Frieden","year":"2017","unstructured":"Frieden TR. Evidence for health decision making\u2014beyond randomized, controlled trials. N Engl J Med. 2017;377:465\u201375. \n                    https:\/\/doi.org\/10.1056\/NEJMra1614394\n                    \n                  .","journal-title":"N Engl J Med."},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/RMHP.S83907","volume":"9","author":"MO Folayan","year":"2016","unstructured":"Folayan MO, Haire BG, Brown B. Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic. Risk Manag Healthc Policy. 2016;9:55\u201365. \n                    https:\/\/doi.org\/10.2147\/RMHP.S83907\n                    \n                  .","journal-title":"Risk Manag Healthc Policy."},{"key":"138_CR27","unstructured":"WHO Ethics Working Group. Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease. WHO Ethics Working Group Meeting, 20\u201321 October. Summary of discussion. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/137509\/1\/WHO_HIS_KER_GHE_14.2_eng.pdf?ua=1\n                    \n                  . Accessed 11 Aug 2017."},{"key":"138_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12910-017-0201-1","volume":"18","author":"E Alirol","year":"2017","unstructured":"Alirol E, Kuesel AC, Guraiib MM, de la Fuente-N\u00fa\u00f1ez V, Saxena A, Gomes MF. Ethics review of studies during public health emergencies\u2014the experience of the WHO ethics review committee during the Ebola virus disease epidemic. BMC Med Ethics. 2017;18:43. \n                    https:\/\/doi.org\/10.1186\/s12910-017-0201-1\n                    \n                   (Erratum. In: BMC Med Ethics. 2017;18:45).","journal-title":"BMC Med Ethics."},{"key":"138_CR29","doi-asserted-by":"publisher","first-page":"e0168975","DOI":"10.1371\/journal.pone.0168975","volume":"12","author":"T Richardson","year":"2017","unstructured":"Richardson T, Johnston AM, Draper H. A systematic review of Ebola treatment trials to assess the extent to which they adhere to ethical guidelines. PLoS ONE. 2017;12:e0168975. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0168975\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"138_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf9547","author":"TK Mackey","year":"2017","unstructured":"Mackey TK, Kohler J, Lewis M, Vian T. Combating corruption in global health. Sci Transl Med. 2017. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaf9547\n                    \n                  .","journal-title":"Sci Transl Med."},{"key":"138_CR31","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/S0140-6736(17)31602-1","volume":"389","author":"GT Keusch","year":"2017","unstructured":"Keusch GT, McAdam KPWJ. Clinical trials during epidemics. Lancet. 2017;389:2455\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31602-1\n                    \n                  .","journal-title":"Lancet"},{"key":"138_CR32","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/S0140-6736(17)31635-5","volume":"389","author":"MP Kieny","year":"2017","unstructured":"Kieny MP, Salama P. WHO R&D Blueprint: a global coordination mechanism for R&D preparedness. Lancet. 2017;389:2469\u201370. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31635-5\n                    \n                  .","journal-title":"Lancet"},{"key":"138_CR33","doi-asserted-by":"publisher","first-page":"e1002042","DOI":"10.1371\/journal.pmed.1002042","volume":"13","author":"LO Gostin","year":"2016","unstructured":"Gostin LO, Tomori O, Wibulpolprasert S, et al. Toward a common secure future: four global commissions in the wake of Ebola. PLoS Med. 2016;13:e1002042. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1002042\n                    \n                  .","journal-title":"PLoS Med."},{"key":"138_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!). Lancet. 2017;389:505\u201318. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)32621-6\n                    \n                  .","journal-title":"Lancet"},{"key":"138_CR35","unstructured":"World Health Organization. Report of a WHO Informal Consultation held in Geneva, Switzerland Influenza Vaccine Response during the Start of a Pandemic Influenza Vaccine Response during the Start of a Pandemic, 29 June\u20131 July, 2015. \n                    https:\/\/www.apps.who.int\/iris\/bitstream\/10665\/207751\/1\/WHO_OHE_PED_GIP_2016.1_eng.pdf\n                    \n                  . Accessed 14 May 2017."},{"key":"138_CR36","unstructured":"US Department of Health and Human Services. Pandemic influenza plan. (2017). \n                    https:\/\/www.cdc.gov\/flu\/pandemic-resources\/pdf\/pan-flu-report-2017.pdf\n                    \n                  . Accessed 20 Jun 2017."},{"key":"138_CR37","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMp1613577","volume":"376","author":"JA R\u00f8ttingen","year":"2017","unstructured":"R\u00f8ttingen JA, Gouglas D, Feinberg M, et al. New vaccines against epidemic infectious diseases. N Engl J Med. 2017;376:610\u20133. \n                    https:\/\/doi.org\/10.1056\/NEJMp1613577\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"138_CR38","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra1208802","volume":"370","author":"HV Fineberg","year":"2014","unstructured":"Fineberg HV. Pandemic preparedness and response\u2013lessons from the H1N1 influenza of 2009. N Engl J Med. 2014;370:1335\u201342. \n                    https:\/\/doi.org\/10.1056\/NEJMra1208802\n                    \n                   (Erratum. In: N Engl J Med. 2015;372:197).","journal-title":"N Engl J Med"},{"key":"138_CR39","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1016\/j.vaccine.2016.09.023","volume":"34","author":"BG Gellin","year":"2016","unstructured":"Gellin BG, Qadri F. Preparing for the unpredictable: The continuing need for pandemic influenza preparedness. Vaccine. 2016;34:5391\u20132. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.023\n                    \n                  .","journal-title":"Vaccine."},{"key":"138_CR40","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1016\/j.vaccine.2017.07.053","volume":"35","author":"A Palache","year":"2017","unstructured":"Palache A, Abelin A, Hollingsworth R, et al. Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. Vaccine. 2017;35:4681\u20136. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.053\n                    \n                  .","journal-title":"Vaccine."},{"key":"138_CR41","unstructured":"World Health Organization. Research and development for potentially epidemic diseases. A blueprint for research and development preparedness and rapid research response 20 March 2017. \n                    https:\/\/www.apps.who.int\/gb\/ebwha\/pdf_files\/WHA70\/A70_10-en.pdf\n                    \n                  . Accessed 28 May 2017."},{"key":"138_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.curtheres.2017.01.007","volume":"84","author":"H Sweiti","year":"2017","unstructured":"Sweiti H, Ekwunife O, Jaschinski T, Lhachimi SK. Repurposed therapeutic agents targeting the Ebola virus: a systematic review. Curr Ther Res Clin Exp. 2017;84:10\u201321. \n                    https:\/\/doi.org\/10.1016\/j.curtheres.2017.01.007\n                    \n                  .","journal-title":"Curr Ther Res Clin Exp."},{"key":"138_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fimmu.2015.00432","volume":"6","author":"SP Morzunov","year":"2015","unstructured":"Morzunov SP, Khaiboullina SF, St Jeor S, Rizvanov AA, Lombardi VC. Multiplex analysis of serum cytokines in humans with hantavirus pulmonary syndrome. Front Immunol. 2015;6:432. \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00432\n                    \n                  .","journal-title":"Front Immunol."},{"key":"138_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","volume":"99","author":"DS Fedson","year":"2013","unstructured":"Fedson DS. Treating influenza with statins and other immunomodulatory agents. Antiviral Res. 2013;99:417\u201335. \n                    https:\/\/doi.org\/10.1016\/j.antiviral.2013.06.018\n                    \n                  .","journal-title":"Antiviral Res."},{"key":"138_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.immuni.2015.08.023","volume":"43","author":"GD Norata","year":"2015","unstructured":"Norata GD, Caligiuri G, Chavakis T, et al. The cellular and molecular basis of translational immunometabolism. Immunity. 2015;43:421\u201334. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2015.08.023\n                    \n                  .","journal-title":"Immunity."},{"key":"138_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nri.2016.136","volume":"17","author":"MP Soares","year":"2017","unstructured":"Soares MP, Teixeira L, Moita LF. Disease tolerance and immunity in host protection against infection. Nat Rev Immunol. 2017;17:83\u201396. \n                    https:\/\/doi.org\/10.1038\/nri.2016.136\n                    \n                  .","journal-title":"Nat Rev Immunol."},{"key":"138_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/505116","volume":"43","author":"DS Fedson","year":"2006","unstructured":"Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis. 2006;43:199\u2013205.","journal-title":"Clin Infect Dis."},{"key":"138_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/1350178X.2013.774845","volume":"20","author":"M Baddeley","year":"2013","unstructured":"Baddeley M. Herding, social influence and expert opinion. J Econ Method. 2013;20:35\u201344.","journal-title":"J Econ Method."},{"key":"138_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15252\/embr.201540637","volume":"16","author":"M Baddeley","year":"2015","unstructured":"Baddeley M. Herding, social influences and behavioural bias in scientific research. EMBO Rep. 2015;16:902\u20135. \n                    https:\/\/doi.org\/10.1155\/2012\/679090\n                    \n                  .","journal-title":"EMBO Rep."},{"key":"138_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1257\/jep.5.1.193","volume":"5","author":"D Kahnemann","year":"1991","unstructured":"Kahnemann D, Knetsch JL, Thaler RH. Anomalies. The endowment effect, loss aversion and status quo bias. J Econ Perspect. 1991;5:193\u2013206.","journal-title":"J Econ Perspect."},{"key":"138_CR51","first-page":"27","volume":"1","author":"M Baddeley","year":"2017","unstructured":"Baddeley M. Experts in policy land\u2014insights from behavioural economics on improving experts\u2019 advice for policy-makers. J Behav Econ Policy. 2017;1:27\u201331.","journal-title":"J Behav Econ Policy."},{"key":"138_CR52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","volume":"17","author":"X Wang","year":"2017","unstructured":"Wang X, Jiang H, Wu P, et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017;17:822\u201332. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(17)30323-7\n                    \n                  .","journal-title":"Lancet Infect Dis."},{"key":"138_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7326\/0003-4819-145-2-200607180-00132","volume":"145","author":"I Starr","year":"2006","unstructured":"Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia. 1976. Ann Intern Med. 2006;145:138\u201340.","journal-title":"Ann Intern Med."},{"key":"138_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/cid\/cit695","volume":"58","author":"DS Fedson","year":"2014","unstructured":"Fedson DS. How will physicians confront the next influenza pandemic? Clin Infect Dis. 2014;58:233\u20137. \n                    https:\/\/doi.org\/10.1093\/cid\/cit695\n                    \n                  .","journal-title":"Clin Infect Dis."},{"key":"138_CR55","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/21645515.2017.1378292","volume":"14","author":"DS Fedson","year":"2018","unstructured":"Fedson DS. Clinician-initiated research on treating the host response to pandemic influenza. Hum Vaccin Immunother. 2018;14:790\u20135. \n                    https:\/\/doi.org\/10.1080\/21645515.2017.1378292\n                    \n                  .","journal-title":"Hum Vaccin Immunother."},{"key":"138_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3201\/eid1503.080857","volume":"15","author":"DS Fedson","year":"2009","unstructured":"Fedson DS. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerg Infect Dis. 2009;15:365\u201371. \n                    https:\/\/doi.org\/10.3201\/eid1503.080857\n                    \n                  .","journal-title":"Emerg Infect Dis."},{"key":"138_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcrc.2017.02.009","volume":"40","author":"AH Rishu","year":"2017","unstructured":"Rishu AH, Marinoff N, Julien L, et al. Time required to initiate outbreak and pandemic observational research. J Crit Care. 2017;40:7\u201310. \n                    https:\/\/doi.org\/10.1016\/j.jcrc.2017.02.009\n                    \n                  .","journal-title":"J Crit Care."},{"key":"138_CR58","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/CCM.0000000000002912","volume":"46","author":"SA Webb","year":"2018","unstructured":"Webb SA, Nichol AD. Bending the pandemic curve: improving decision-making with clinical research. Crit Care Med. 2018;46:442\u20136. \n                    https:\/\/doi.org\/10.1097\/CCM.0000000000002912\n                    \n                  .","journal-title":"Crit Care Med."},{"key":"138_CR59","unstructured":"The ISARIC-WHO Clinical Characterization Protocol for Severe Emerging Infections. \n                    https:\/\/isaric.tghn.org\/protocols\/clinical-characterization-protocol\/\n                    \n                  . Accessed 16 Aug 2017."},{"key":"138_CR60","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1057\/palgrave.jphp.3200147","volume":"28","author":"DS Fedson","year":"2007","unstructured":"Fedson DS, Dunnill P. From scarcity to abundance: pandemic vaccines and other agents for \u201chave not\u201d countries. J Public Health Policy. 2007;28:322\u201340.","journal-title":"J Public Health Policy"}],"container-title":["Journal of Public Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1057\/s41271-018-0138-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/s41271-018-0138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/s41271-018-0138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T11:06:19Z","timestamp":1585047979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1057\/s41271-018-0138-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1057\/s41271-018-0138-8","relation":{},"ISSN":["0197-5897","1745-655X"],"issn-type":[{"value":"0197-5897","type":"print"},{"value":"1745-655X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"16 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}